Related Experiment Video
Updated: Sep 28, 2025
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus
Toshiki Hiramatsu1, Kazunori Tobino2
1Department of Critical Care Medicine Iizuka Hospital Iizuka Japan.
Abstract:
We report a fatal case of methicillin-resistant Staphylococcus aureus (MRSA)-induced necrotizing pneumonia that was refractory to adequate vancomycin treatment (trough value, 13.1 µg/ml), drainage of hydropneumothorax, and veno-arterial extracorporeal membrane oxygenation. Despite appropriate treatment, MRSA infection can cause rapidly progressive disease with a high-case fatality rate.
Insights
A severe methicillin-resistant Staphylococcus aureus (MRSA) infection caused fatal necrotizing pneumonia. Even with vancomycin treatment and advanced life support, the patient did not survive, highlighting MRSA
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Necrotizing pneumonia is a severe lung infection.
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen.
- Treatment challenges exist for severe MRSA infections.
Purpose of the Study:
- To report a fatal case of MRSA-induced necrotizing pneumonia.
- To illustrate the limitations of standard treatments in severe MRSA infections.
- To emphasize the rapid progression and high fatality rate of this condition.
Main Methods:
- Case report of a patient with MRSA-induced necrotizing pneumonia.
- Details of treatment including vancomycin, hydropneumothorax drainage, and ECMO.
- Analysis of treatment response and clinical outcome.
Main Results:
- The patient developed severe necrotizing pneumonia due to MRSA.
- Treatment with vancomycin achieved adequate trough levels but was ineffective.
- Despite drainage and veno-arterial extracorporeal membrane oxygenation, the patient experienced a fatal outcome.
Conclusions:
- MRSA can cause rapidly progressive and fatal necrotizing pneumonia.
- Adequate vancomycin treatment and advanced life support may not be sufficient.
- This case underscores the challenges in managing severe MRSA lung infections.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: